Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop

D Howard, R Cordell, JE McGowan Jr… - Clinical infectious …, 2001 - JSTOR
Health systems administrators and clinicians need refined calculations of the attributable
cost of infections due to drug-resistant microorganisms to develop and assess cost-effective …

The global impact of drug resistance

DH Howard, RD Scott, R Packard… - Clinical Infectious …, 2003 - academic.oup.com
Measuring the impact of drug resistance is an important step in understanding the scope of
the problem and formulating policies to limit the emergence and spread of resistant …

[图书][B] Extending the cure: policy responses to the growing threat of antibiotic resistance

R Laxminarayan, A Malani, D Howard, DL Smith - 2010 - api.taylorfrancis.com
Our ability to treat common bacterial infections with antibiotics goes back only 65 years.
However, the authors of this report make it clear that sustaining a supply of effective and …

Does Phage Therapy Need a Pan-Phage?

P Bozidis, E Markou, A Gouni, K Gartzonika - Pathogens, 2024 - mdpi.com
The emergence of multidrug-resistant bacteria is undoubtedly one of the most serious global
health threats. One response to this threat that has been gaining momentum over the past …

The Boskin Commission report: A retrospective one decade later

RJ Gordon - 2006 - nber.org
This paper provides a retrospective on the 1996 Boskin Commission Report, Toward a More
Accurate Measure of the Cost of Living, and its famous estimate that the CPI in 1995-96 was …

The costs and benefits of intensive treatment for cardiovascular disease

DM Cutler, MB McClellan, JP Newhouse - 1998 - nber.org
This paper examines the causes and consequences of reductions in cardiovascular disease
mortality, and in particular heart attack mortality, over the past several decades. Analysis of …

Health care productivity

MN Baily, AM Garber, ER Berndt, DM Cutler - Brookings Papers on …, 1997 - JSTOR
IN ALL OF THE INDUSTRIAL COUNTRIES, a high fraction of gross domestic product (GDP),
ranging from approximately 7 percent in the United Kingdom to 14 percent in the United …

[PDF][PDF] An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts

ER Berndt, A Bhattacharjya, DN Mishol… - Journal of Mental …, 2002 - icmpe.org
Background: We are not aware of any published research that quantifies and compares the
importance of effectiveness and side effects for pharmaceutical sales, and that …

What's different about health? Human repair and car repair in national accounts and in national health accounts

JE Triplett - Medical care output and productivity, 2001 - degruyter.com
1.1 Background Although one might expect that measuring health care output would entail
in some manner measuring “health,” most prior economic measurement in health care has …

Antibiotic effectiveness: new challenges in natural resource management

M Herrmann, R Laxminarayan - Annu. Rev. Resour. Econ., 2010 - annualreviews.org
Problems of optimal natural resource extraction that were first addressed by economists in
the contexts of fisheries and forests have reemerged in the context of a newly recognized …